The U.S.-based pharmaceutical giant Pfizer reported Tuesday that it brought in a record-breaking $100.3 billion in revenue in 2022 and $31.4 billion in profit, sums that campaigners decried as 'sickening' in the face of an ongoing pandemic and persistent inequities in coronavirus vaccine access.
'But not content with doubling its revenues with a pandemic windfall, they are now still moving to aggressively hike the price of Covid-19 booster doses, putting even more pressure on already struggling public health systems.' 'Their latest record-breaking revenues are further proof that the company treated the pandemic as an opportunity to enrich its shareholders,' Bierley added. 'We can't allow Big Pharma companies to hold us to ransom in this way.